Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Cytokinetics Incorporated, 3 years.
Cytokinetics Incorporated
Director
Foghorn Therapeutics Inc.
Director
Ionis Pharmaceuticals Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Foghorn Therapeutics Inc. June 24, 202696.3%
-
Cytokinetics Incorporated May 14, 202596.7%
-
Foghorn Therapeutics Inc. June 21, 202399.9%
-
Ionis Pharmaceuticals Inc. June 1, 202384.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $71.48 | $357,400 |
| Jun 1, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $74.08 | $370,400 |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| Apr 15, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −4,466 | $76.19 | $340,265 |
| Apr 15, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −534 | $76.97 | $41,102 |
| Mar 2, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $61.21 | $306,050 |
| Feb 11, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,000 | $82.72 | $413,600 |
| Nov 19, 2025 | Cytokinetics Incorporated | Open-market sale | −5,000 | $64.73 | $323,650 |
| Oct 15, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,000 | $71.74 | $358,700 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −10,750 | $50.42 | $542,015 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −9,250 | $51.49 | $476,283 |
| Aug 6, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −4,600 | $41.87 | $192,602 |
| Aug 6, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −400 | $42.63 | $17,052 |
| Jul 15, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +4,079 | — | — |
| May 14, 2025 | Cytokinetics Incorporated | Grant or award | +7,333 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.